Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial
Article in Scientific Reports (August 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Scientific Reports (August 2022)
Article in Cerebral Cortex Communications (July 2022)
Article in Frontiers in Psychiatry (April 2022)